5.3.2 Herpes virus infections

5.3.2.1 Herpes simplex and varicella-zoster infection

Aciclovir
  • Tablets 200mg, 400mg, 800mg (£0.45, £0.45, £0.82 = (price for guide only) 10 tablets)
  • Dispersible tablets 200mg, 400mg, 800mg (£0.46, £2.14, £3.14 = (price for guide only) 10 tablets)
  • Suspension 200mg/5ml, 400mg/5ml (£35.76 = 125ml, £39.47 = 100ml)
  • Intravenous infusion 250mg/10ml, 500mg/20ml, 1g/40ml (see note 1)

Indications

Notes

  1. For intravenous administration, refer to the manufacturer's Summary of Product Characteristics (SPC) or the BNF for the dose according to indication as the oral and intravenous doses differ
Valaciclovir
  • Tablets 500mg (£1.96 = 10)

Indications

5.3.2.2 Cytomegalovirus

Foscarnet
  • IV infusion 24mg/ml, 250ml bottle
Ganciclovir
  • Intravenous Infusion 500mg
Letermovir
  • Tablets 240mg

Notes

  1. NICE TA591: Letermovir (Prevymis) is recommended as an option for preventing cytomegalovirus (CMV) reactivation and disease after an allogeneic haematopoietic stem cell transplant (HSCT) in adults who are seropositive for CMV (July 2019)
Valganciclovir
  • Tablets 450mg
  • Powder for oral solution 50mg/ml

 

Home > Formulary > Chapters > 5. Infections > 5.3 Antiviral drugs > 5.3.2 Herpes virus infections

 

  • First line
  • Second line
  • Specialist
  • Hospital